Feasibility of a Multi-omics Platform for Hematological Malignancies | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Feasibility of a Multi-omics Platform for Hematological Malignancies	Blood Protein Disorders, Hemic and Lymphatic Diseases, Myeloproliferative Disorders, Neoplasms by Histologic Type, acute leukemia, bone marrow disorder, cardiovascular disorder, chronic leukemia, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell myeloma, plasma cell neoplasm, vascular disorder, vascular hemostatic disease	Recruiting	Not applicable	2026-03-03		NCT07445438

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Azienda Ospedaliero-Universitaria di Parma	26

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
University of Parma	Parma	Italy	2